Mira Pharmaceuticals Financials - Benzinga

Mira Pharmaceuticals Inc

MIRANASDAQ

Trade with Public

Trade with Public

$0.7593

0.03975.52%

At close: Sep 16, 5:00 PM EST

$0.7700

0.05047%

Pre-Market: 7:17 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Mira Pharmaceuticals Financials

Mira Pharmaceuticals (MIRA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Mira Pharmaceuticals Q3 EPS $(1.18) Misses $(0.08) Estimate

Mira Pharmaceuticals (NASDAQ:MIRA) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of $(0.08) by 1375 percent. This is a 742.86 percent decrease over losses of $(0.14) per share

Benzinga Newsdesk

Dow Dips Over 100 Points; US Crude Oil Inventories Surge

Avi Kapoor

Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings

Avi Kapoor

PRO
Mira Pharmaceuticals Q2 EPS $(0.09) Beats $(0.13) Estimate

Mira Pharmaceuticals (NASDAQ:MIRA) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.13) by 30.77 percent. This is a 18.18 percent increase over losses of $(0.11) per share

Benzinga Newsdesk

Heico, PDD Holdings And 3 Stocks To Watch Heading Into Monday

Avi Kapoor

Dow Edges Lower; Verizon Shares Fall After Q2 Results

Avi Kapoor